BioMarin Pharmaceutical, Inc. (BMRN)

61.42 -1.20 (-1.92%) USD  |  NASDAQ  |  Feb 25, 16:00
61.42 0.00 (0.00%) After-Hours: 17:34
More

BioMarin Pharmaceutical Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. --
Merck & Co., Inc. --
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade